Literature DB >> 17495185

Probable blind spot in the International Diabetes Federation definition of metabolic syndrome.

Hsin-Jen Chen1, Wen-Harn Pan.   

Abstract

OBJECTIVES: The International Diabetes Federation (IDF) proposed a novel definition of the metabolic syndrome (MS) in 2005, which designated central obesity as mandatory. The new National Cholesterol Education Program (NCEP) version, announced by the American Heart Association and National Heart Lung and Blood Institute in October 2005, did not favor any of the five components. We set out to compare the cardiovascular profiles of patients cross-defined by these two definitions to shed light on the differential meanings of the two. RESEARCH METHODS AND PROCEDURES: We analyzed data from 2608 non-institutionalized adults (> or =19 years old) in the National Nutrition and Health Survey in Taiwan, who had complete data for the five MS defining components. Both definitions adopted lower cut-points for fasting glucose and race-specific cut-points for waist circumference.
RESULTS: Under the IDF's and new NCEP's definitions, the MS prevalence was 6.2% and 11.6% in men and 12.6% and 16.5% in women, respectively. Although the two definitions had high agreement, IDF failed to pick up approximately 4% to 5% of people with more than three MS component disorders but a waist circumference less than the cut-point. Subjects whose physical conditions only satisfied NCEP's definition had similar or worse metabolic profiles than those whose conditions satisfied both IDF's definition and the new NCEP's definition. DISCUSSION: The IDF definition would fail to identify a portion of people who have more than three MS component disorders but a small waistline. Further research and discussion are needed on whether and how to implement the IDF's definition.

Entities:  

Mesh:

Year:  2007        PMID: 17495185     DOI: 10.1038/oby.2007.633

Source DB:  PubMed          Journal:  Obesity (Silver Spring)        ISSN: 1930-7381            Impact factor:   5.002


  8 in total

1.  Non-alcohol fatty liver disease in Asia: Prevention and planning.

Authors:  Sara Ashtari; Mohamad Amin Pourhoseingholi; Mohamad Reza Zali
Journal:  World J Hepatol       Date:  2015-07-08

2.  The relation of metabolic syndrome according to five definitions to cardiovascular risk factors--a population-based study.

Authors:  Cheng-Chieh Lin; Chiu-Shong Liu; Chia-Ing Li; Wen-Yuan Lin; Ming-May Lai; Tsann Lin; Pei-Chia Chang; Yih-Dar Lee; Ching-Chu Chen; Chih-Hsueh Lin; Chuan-Wei Yang; Chih-Yi Hsiao; Walter Chen; Tsai-Chung Li
Journal:  BMC Public Health       Date:  2009-12-23       Impact factor: 3.295

3.  Protective effects of salivary factors in dental caries in diabetic patients of Pakistan.

Authors:  Muhammad Jawed; Rashid N Khan; Syed M Shahid; Abid Azhar
Journal:  Exp Diabetes Res       Date:  2012-06-24

Review 4.  The metabolic syndrome, oxidative stress, environment, and cardiovascular disease: the great exploration.

Authors:  Rebecca Hutcheson; Petra Rocic
Journal:  Exp Diabetes Res       Date:  2012-07-09

5.  Metabolic syndrome according to different definitions in a rapidly developing country of the African region.

Authors:  Clara Kelliny; Julita William; Walter Riesen; Fred Paccaud; Pascal Bovet
Journal:  Cardiovasc Diabetol       Date:  2008-09-18       Impact factor: 9.951

6.  The IDF Definition Is Better Suited for Screening Metabolic Syndrome and Estimating Risks of Diabetes in Asian American Adults: Evidence from NHANES 2011-2016.

Authors:  Lin Zhu; Cody Spence; Jenny Wei Yang; Grace X Ma
Journal:  J Clin Med       Date:  2020-11-28       Impact factor: 4.241

7.  Central obesity in males affected by a dyslipidemia-associated genetic polymorphism on APOA1/C3/A4/A5 gene cluster.

Authors:  M-C Hsu; C-S Chang; K-T Lee; H-Y Sun; Y-S Tsai; P-H Kuo; K-C Young; C-H Wu
Journal:  Nutr Diabetes       Date:  2013-03-04       Impact factor: 5.097

8.  Analysis of agreement among definitions of metabolic syndrome in nondiabetic Turkish adults: a methodological study.

Authors:  Ahmet Selcuk Can; Thomas P Bersot
Journal:  BMC Public Health       Date:  2007-12-19       Impact factor: 3.295

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.